NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,010.00
-10.00 (-0.50%)
Last updated: Jul 21, 2025

NGeneBio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21
50,57732,41171,664116,027201,381
Market Cap Growth
-52.43%-54.77%-38.23%-42.38%-
Enterprise Value
54,81840,75456,79789,239-
Last Close Price
2020.001642.004897.308173.9214269.12
PS Ratio
7.385.7016.4710.5328.11
PB Ratio
3.441.834.414.585.92
P/TBV Ratio
7.703.544.974.916.23
EV/Sales Ratio
8.007.1613.058.10-
Debt / Equity Ratio
0.600.510.710.450.21
Asset Turnover
0.200.150.090.22-
Inventory Turnover
2.091.911.933.29-
Quick Ratio
0.490.660.981.253.22
Current Ratio
0.740.931.141.493.40
Return on Equity (ROE)
-99.16%-82.15%-61.88%-33.17%-
Return on Assets (ROA)
-28.47%-26.71%-17.05%-10.75%-
Return on Capital (ROIC)
-40.43%-36.93%-26.03%-13.78%-
Earnings Yield
-24.12%-38.96%-17.82%-8.43%-4.19%
FCF Yield
-25.21%-38.77%-13.33%-7.63%-5.24%
Buyback Yield / Dilution
-24.68%-31.30%-1.66%-0.89%-
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.